Source: International Congress 2018 – PG16 Advanced cardiopulmonary exercise testing



Rating:

Share or cite this content

Citations should be made in the following way:
P. Laveneziana (Paris Cedex 13, France). The prognostic role of cardiopulmonary exercise testing in disease. International Congress 2018 – PG16 Advanced cardiopulmonary exercise testing

Member's Comments

No comment yet.

Related content which might interest you: The prognostic significance of cardiopulmonary exercise in IPF Source: Annual Congress 2011 - What is new in the approach to pulmonary fibrosis? Year: 2011 The role of cardiopulmonary exercise test in identifying pulmonary veno-occlusive disease Source: Eur Respir J, 57 (6) 2100115; 10.1183/13993003.00115-2021 Year: 2021 The prognostic value of cardiopulmonary exercise testing in interstitial lung disease: a systematic review Source: ERJ Open Res, 6 (3) 00027-2020; 10.1183/23120541.00027-2020 Year: 2020 The prognostic value of cardiopulmonary exercise testing in idiopathic pulmonary fibrosis Source: Annual Congress 2011 - The prognostic value of cardiopulmonary exercise testing Year: 2011 Cardiopulmonary exercise test as prognostic tool in patients with idiopathic pulmonary fibrosis Source: Annual Congress 2007 - Considerations in the management of idiopathic pulmonary fibrosis and other interstitial lung diseases Year: 2007 Any role for cardiopulmonary exercise test as an outcome in severe asthmatic patients after the initiation of biological therapy? Source: Virtual Congress 2020 – From respiratory physiology to clinical practice: exercise and respiratory muscles Year: 2020 Cardiopulmonary exercise testing as non-invasive tool for CTEPH treatment effect assessment Source: Virtual Congress 2021 – Hypoxia, exercise and respiratory function in pathophysiological conditions Year: 2021 Prognostic predictors for survival in patients with COPD using cardiopulmonary testing Source: Eur Respir J 2002; 20: Suppl. 38, 285s Year: 2002 The evolving role of exercise testing in the pulmonary patient Source: Annual Congress 2009 - PG17 Cardiopulmonary exercise testing in the evaluation of the respiratory patient Year: 2009 The role of cardiopulmonary exercise testing in the investigation of complex unexplained breathlessness Source: International Congress 2017 – Evaluating lung function, dyspnoea and related respiratory diseases Year: 2017 Cardiopulmonary exercise testing in the evaluation of the indication and efficacy of pulmonary rehabilitation Source: ERS Course 2020 - Pulmonary rehabilitation Year: 2020 The role of cardiopulmonary exercise testing in assessment of the severity of patients with PAH associated with congenital heart disease. Source: International Congress 2019 – Pulmonary hypertension: clinical Year: 2019 Cardiopulmonary exercise test provides valuable information on function and prognosis in PAH Source: International Congress 2018 – Pulmonary hypertension: right ventricle function, haemodynamics and exercise Year: 2018 Predicting poor outcome in COPD-heart failure overlap: The role of resting echocardiography and cardiopulmonary exercise testing Source: International Congress 2015 – Unravelling the mechanisms of symptoms and exercise limitationas in disease Year: 2015 Exercise testing in the prognostic evaluation of patients with lung and heart diseases Source: ISSN=ISSN 1025-448x, ISBN=ISBN 978-1-904097-49-5, page=195 Year: 2007 The prognostic value of exercise testing Source: Breathe 2009; 5: 229-234 Year: 2009 The sPAP/VO2 ratio during cardiopulmonary exercise testing as predictor of manifest pulmonary hypertension Source: Annual Congress 2012 - Pulmonary circulation: clinical end-points and clinical physiology Year: 2012 Ventilatory response to exercise in cardiopulmonary disease: the role of chemosensitivity and dead space Source: Eur Respir J, 51 (2) 1700860; 10.1183/13993003.00860-2017 Year: 2018 Exercise testing in the prognostic evaluation of patients with lung and heart diseases Source: Eur Respir Monogr 2018; 80: 222-234 Year: 2018